# US 2022/0032286 A1 · Temperature controlled valves for paper-based microfluidic systems

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0032286 A1
- Document ID: US20220032286A1
- Status: Published application
- Kind: A1
- Application number: 17/402,496
- Filed: 2021-08-13
- Published: 2022-02-03
- Earliest claimed: 2016-04-19
- Assignees: Purdue Research Foundation
- Applicants: Purdue Research Foundation
- Inventors: Jacqueline C. Linnes; Megan Zaiyi Chiu; Rui Shen
- Web page: https://patentgrep.com/patent/US20220032286A1

## CPC

- B01L 3/5027: {by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip}
- B01L 3/5023: {with a sample being transported to, and subsequently stored in an absorbent for analysis}
- B01L 7/52: {with provision for submitting samples to a predetermined sequence of different temperatures, e.g. for treating nucleic acid samples}
- C12Q 1/6846: {Common amplification features}
- C12Q 1/703: {Viruses associated with AIDS}
- F16K 99/0032: {using phase transition or influencing viscosity}
- F16K 99/0036: {operated by temperature variations}
- G01N 33/54388: {based on lateral flow}
- G01N 33/558: using diffusion or migration of antigen or antibody {(immunochromatographic test strips G01N33/54387)}
- B01L 2300/0825: Test strips
- B01L 2300/126: Paper
- B01L 2300/1827: using resistive heater
- B01L 2400/0406: capillary forces
- B01L 2400/0677: phase change valves; Meltable, freezing, dissolvable plugs; Destructible barriers
- G01N 2333/005: from viruses
- G01N 2333/195: from bacteria
- Y02A 50/30: Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
- B01L: CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- F16K: VALVES; TAPS; COCKS; ACTUATING-FLOATS; DEVICES FOR VENTING OR AERATING {(devices for emptying and evacuating the excess liquid in valves or conduits F16L55/07)}
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

The present invention relates to a low-cost, thermally reversible valve for paper-fluidic diagnostic devices. In particular, this invention demonstrates a tunable valve mechanism fabricated by wax-ink printing and localized heating via thin-film resistors to sequentially release liquids through a cellulose or nitrocellulose membrane. The wax-ink valve can obstruct fluid flow for a sustained time and are thermally actuated to release a controlled amount of liquid past the valve. This integrated paper-fluidic diagnostic assay device requires minimal user involvement, can be easily manufactured and tuned to meet various fluid delivery timing and incubation needs.

## Claims

### Claim 1

A method for testing a sample for the presence or absence of a nucleic acid of said sample comprising the steps of:
providing an assay device comprising:
a first thermally reversible barrier, wherein the first thermally reversible barrier defines an assay area, and a plurality of heating and temperature control components comprising a conductive ink printed resistor operatively positioned proximate said first thermally reversible barrier, wherein the first thermally reversible barrier includes an associated inlet and an associated outlet across a membrane and selectively operates according to four states: 1) an un-actuated state, where the first thermally reversible barrier is placed adjacent the membrane whereby fluid is free to travel across the membrane; 2) an actuated state when temperature of the first thermally reversible barrier is raised to a first predetermined threshold, where the first thermally reversible barrier melts and permeates into the membrane whereby fluid is stopped from travelling across the membrane, after which the temperature is allowed to be at or below the first predetermined threshold; 3) a closed state when temperature of the first thermally reversible barrier is below a second predetermined threshold, where the first thermally reversible barrier remains permeated in the membrane thereby fluid is stopped from travelling across the membrane; and 4) an open state when temperature of the first thermally reversible barrier is above the second predetermined threshold, where the first thermally reversible barrier re-melts whereby fluid in presence of a fluid pressure differential across the membrane is allowed to travel across the membrane; and
a second thermally reversible barrier disposed proximate a second conductive ink printed resistor, wherein the first thermally reversible barrier is positioned between a sample application area and an amplification area and the second thermally reversible barrier is positioned between the amplification area and a detection area, wherein the second thermally reversible barrier includes an associated inlet and an associated outlet and operates according to the four states of the first thermally reversible barrier, wherein the amplification area allows for amplification of a biological molecule of interest present in a sample;
actuating the first thermally reversible barrier whereby temperature of the first thermally reversible barrier is raised to the first predetermined threshold;
placing a sample in the sample application area, whereby the sample is allowed to flow through the first thermally reversible barrier into the amplification area;
closing the first thermally reversible barrier;
amplifying the biological molecule of interest;
actuating the second thermally reversible barrier whereby temperature of the second thermally reversible barrier is raised to the first predetermined threshold; and
determining the presence or absence of the biological molecule of interest in the detection area.

### Claim 2 (depends on 1)

The method of claim 1, wherein the amplification is by way of heating the amplification area.

### Claim 3 (depends on 2)

The method of claim 2, wherein the heating comprises heating the amplification area to a temperature of about 65° C.

### Claim 4 (depends on 1)

The method of claim 1, wherein the amplification is by way of introducing an amplification reagent provided in the amplification area.

### Claim 5 (depends on 1)

The method of claim 1, wherein the first predetermined threshold is about 65° C. and the second predetermined threshold is at least about 68° C.

### Claim 6 (depends on 1)

The method of claim 1, wherein the first conductive ink printed resistor is made of silver, carbon, or gold ink.

### Claim 7 (depends on 1)

The method of claim 1, wherein power supply for said first conductive ink printed resistor is powered by a phone, tablet, personal computer, or battery, and temperature is regulated via a microcontroller.

### Claim 8 (depends on 1)

The method of claim 1, wherein the first and second thermally reversible barriers comprise a phase change material, including agarose, fatty acids, gelatin, wax, or a combination thereof.

### Claim 9 (depends on 1)

The method of claim 1, wherein the assay device is a paper-based nucleic acid amplification and detection assay device.

### Claim 10 (depends on 9)

The method of claim 9, wherein the paper-based nucleic acid amplification assay device is a detection device for virus, including HIV, Zika Virus, or for a bacterial pathogen, including E. coli, Vibrio cholerae, Staphylococcus aureus, group B streptococci, Klebsiella pneumoniae, Bordetella pertussis, Bordetella bronchiseptica, or for malaria parasites.
